Phase two clinical trial of limited stage lymphoblastic lymphoma.

Phase two clinical trial of limited stage lymphoblastic lymphoma. - Clinical trial of limited stage childhood lymphoblastic lymphoma

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000002213

Enrollment

Registered

2009-07-26

Start date

2005-02-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Limited stage lymphoblastic lymphoma

Interventions

Treatment regimen has fundamentally BFM backbone with reinduction phase

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Newly diagnosed patients with limited T and B cell lymphoblastic lymphoma

Exclusion criteria

Exclusion criteria: 1, Down's syndrome 2, previous malignancy of any type 3, Prior stem cell or organ transplantation 4, Congenital or acquired immunodeficiency

Design outcomes

Primary

Measure	Time frame
3 year event-free survival	—

Secondary

Measure	Time frame
(1) 3year overall survival (2)Incidence of therapy-rerated severe toxicity	—

Countries

Japan

Contacts

Public ContactShosuke Sunami

Japanese Red Cross Narita Hospital Department of Pediatrics

s-sunami@sc4.so-net.ne.jp0476-22-2311

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026